Search Results

Total: 2 , 1/1

Show Home Prev Next End page: GO

Author:(Seren M. GEDALLOVICH)

1.Reply to correspondence on “Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy”

Seren M. GEDALLOVICH ; Paul Y. KWO

Clinical and Molecular Hepatology 2024;30(4):1050-1052

2.Meeting the challenges of hepatocellular carcinoma post sustained virologic response in the post-direct- acting antiviral era: A path forward: Editorial on “Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication”

Seren M. GEDALLOVICH ; Paul Y. KWO

Clinical and Molecular Hepatology 2024;30(4):677-681

Sort by

Result Analysis

Display Mode

Brief Abstract

Selected Records All Records

Output Records

All Records(≤500)
Selected Records
All Records on Page
Records To (≤500)

File Type

Normal
NoteExpress
Refworks
EndNote
XML

Print

Save

E-mail

Total: 2 , 1/1 Show Home Prev Next End page: GO